Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
62 Cards in this Set
- Front
- Back
- 3rd side (hint)
Cimetidine, ranitidine, famotidine, nizatidine
|
H2 blockers
MECH: reversibly block histamine H2 receptors → ↓H+ secretion by parietal cells USE: peptic ulcer, gastritis, mild GERD TOX: Cimetidine: inhibits P-450, antiandrogenic, cross BBB (confusion, dizziness, HA) and placenta; cime- and ranitidine ↓ renal excretion of creatinine |
GI
|
|
Omeprazole, lansoprazole
|
PPI
MECH: irreversibly inhibit H+/K+ ATPase in parietal cells USE: peptic ulcer, gastritis, GERD, Zollinger-Ellison |
GI
|
|
Bismuth, sucralfate
|
MECH: binds ulcer base providing physical protection and allowing HCO3- secretion to reestablish pH gradient in mucus layer
USE: ↑ ulcer healing, travelers diarrhea, H. pylori triple therapy |
GI
|
|
Misoprostol
|
MECH: PGE1 analog →↑ production and secretion of gastric mucous barrier, ↓acid production
USE: prevention of NSAID-induced pep ulcers; maintenance of PDA; post-coital abortifacient TOX: diarrhea, abortifacient |
GI, Congenital, Repro
|
|
Pirenzepime, propantheline
|
Muscarinic antagonists
MECH: block M1 receptors on ECL →↓histamine secretion; block M3 on parietal cells →↓H+ secretion USE: Peptic ulcer TOX: tachycardia, dry mouth, difficulty focusing |
GI
|
|
Infliximab
|
MECH: monoclonal antibody to TNF-alpha → ↓inflammation
USE: Crohn's dz, RA, ankylosing spondylitis TOX: respiratory infection, fever, hypotension, TB reactivation |
GI, Rheum
|
|
Sulfasalazine
|
MECH: Combo of sulfapyridine (antibacterial) and mesalamine (anti-inflam)
USE: IBD (Crohns's and UC) TOX: malaise, nausea, sulfonamide tox, reversible oligospermia |
GI
|
|
Ondansetron
|
Central-acting antiemetic
MECH: 5-HT3 antagonist USE: Post op vomiting, CA chemotherapy TOX: HA, constipation |
GI
|
|
Cisapride
|
Pro-kinetic agent
MECH: Acts through seratonin receptors to ↑ACh release at myenteric plexus →↑esophageal tone and ↑ gastroduodenal contractility USE: no longer used TOX: torsades de pointes with other drugs (erythromycin, ketoconazole, nefazodone, fluconazole) |
GI
|
|
Metoclopramide
|
Pro-kinetic agent
MECH: D2 receptor antagonist →↑resting tone, contractility, LES tone, motility; does not increase transit time through colon USE: diabetic and post op gastroparesis TOX: ↑Parkinson's effects, restlessness, drowsines, fatigue, depression, nausea, constipation |
GI
|
|
Metformin
|
Biguanide
MECH: ↓hepatic glucose output (↓gluconeogensis); sensitizes the liver to insulin. USE: Oral hypoglycemic TOX: lactic acidosis; *does not cause hypoglycemia |
Diabetes
|
|
Tolbutamide
|
Sulfonylureas - 1st generation
MECH:Close ATP/ADP K-channel → beta-cell depolarization →↑Ca influx → insulin release USE: Type 2 DM only (must have some islet function) TOX: disulfiram-like effects |
Diabetes
|
|
Chlorpropamide
|
Sulfonylureas - 1st generation
MECH:Close ATP/ADP K-channel → beta-cell depolarization →↑Ca influx → insulin release USE: Type 2 DM only (must have some islet function) TOX: disulfiram-like effects |
Diabetes
|
|
Glyburide
|
Sulfonylureas - 2nd generation (more potent)
MECH:Close ATP/ADP K-channel → beta-cell depolarization →↑Ca influx → insulin release USE: Type 2 DM only (must have some islet function) TOX: hypoglycemia |
Diabetes
|
|
Glimepiride
|
Sulfonylureas - 2nd generation (more potent)
MECH:Close ATP/ADP K-channel → beta-cell depolarization →↑Ca influx → insulin release USE: Type 2 DM only (must have some islet function) TOX: hypoglycemia |
Diabetes
|
|
Glipizide
|
Sulfonylureas - 2nd generation (more potent)
MECH:Close ATP/ADP K-channel → beta-cell depolarization →↑Ca influx → insulin release USE: Type 2 DM only (must have some islet function) TOX: hypoglycemia |
Diabetes
|
|
Rosiglitazone
|
Glitazone
MECH: Activate nuclear receptors (PPAR-γ) →↑insulin sensitivity (↓insulin resistance) USE: Type 2 DM (monotherapy or combined with other agents) TOX: Weight gain, edema (CHF), *MI |
Diabetes
|
|
Pioglitazone
|
Glitazone
MECH: Activate nuclear receptors (PPAR-γ) →↑insulin sensitivity (↓insulin resistance) USE: Type 2 DM (monotherapy or combined with other agents) TOX: Weight gain, edema (CHF) |
Diabetes
|
|
Acarbose
|
α-glucosidase inhibitor
MECH: Inhibit intestinal brush border α-glucosidases → delayed sugar hydrolysis and glucose absorption → ↓postprandial hyperglycemia USE: Type 2 DM TOX: flatulence and diarrhea (limit use) |
Diabetes
|
|
Miglitol
|
α-glucosidase inhibitor
MECH: Inhibit intestinal brush border α-glucosidases → delayed sugar hydrolysis and glucose absorption → ↓postprandial hyperglycemia USE: Type 2 DM TOX: flatulence and diarrhea (limit use) |
Diabetes
|
|
Lispro
|
Insulin - Fast acting
MECH: Binds insulin receptor → Liver: ↑glucose storage (glycogen) Muscle: ↑glycogen and protein synthesis; K+ uptake Fat: aids TG storage USE: Type 1 DM; life-threatening hyperkalemia, stress-induced hyperglycemia TOX: hypoglycemia |
Diabetes
|
|
Insulin
|
Insulin - Short acting
MECH: Binds insulin receptor → Liver: ↑glucose storage (glycogen) Muscle: ↑glycogen and protein synthesis; K+ uptake Fat: aids TG storage USE: Type 1 DM; life-threatening hyperkalemia, stress-induced hyperglycemia TOX: hypoglycemia |
Diabetes
|
|
NPH (“Neutral protamine Hagedorn”)
|
Insulin - intermediate acting (slow solubilization)
MECH: Binds insulin receptor → Liver: ↑glucose storage (glycogen) Muscle: ↑glycogen and protein synthesis; K+ uptake Fat: aids TG storage USE: Type 1 DM; life-threatening hyperkalemia, stress-induced hyperglycemia TOX: hypoglycemia |
Diabetes
|
|
Lente
|
Insulin - long acting
MECH: Binds insulin receptor → Liver: ↑glucose storage (glycogen) Muscle: ↑glycogen and protein synthesis; K+ uptake Fat: aids TG storage USE: Type 1 DM; life-threatening hyperkalemia, stress-induced hyperglycemia TOX: hypoglycemia |
Diabetes
|
|
Ultralente
|
Insulin - long acting
MECH: Binds insulin receptor → Liver: ↑glucose storage (glycogen) Muscle: ↑glycogen and protein synthesis; K+ uptake Fat: aids TG storage USE: Type 1 DM; life-threatening hyperkalemia, stress-induced hyperglycemia TOX: hypoglycemia |
Diabetes
|
|
Orlistat
|
MECH: inhibits pancreatic lipases → altered fat absorption and metabolism
USE: long-term obesity management (with a modified diet) TOX: Steatorrhea, GI discomfort, reduced absorption of fat-soluble vitamins, HA |
endocrine
|
|
Sibutramine
|
MECH: 5HT & norepi reuptake inhibitor → appetite suppression (centrally acting)
USE: short- and long-term obesity managment TOX: HTN, tachycardia |
endocrine
|
|
Propylthiouracil
|
MECH: inhibits thyroperoxidase (organification and coupling of thyroid hormone synthesis); ↓ peripheral conversion of T4 to T3
USE: Hyperthyroidism TOX: skin rash, agranulocytosis, aplastic anemia |
endocrine
|
|
Methimazole
|
MECH: inhibits thyroperoxidase (organification and coupling of thyroid hormone synthesis)
USE: Hyperthyroidism TOX: skin rash, agranulocytosis (sore throat, fever, arthralgias), aplastic anemia |
endocrine
|
|
Growth Hormone (GH)
|
USE: GH deficiency, Turner's syndrome
|
endocrine
|
|
Somatostatin
|
MECH: Inhibits growth hormone, glucagon, insulin, LH, 5HT, gastin VIP
USE: acromegaly, carcinoid, gastrinoma, glucagonoma |
endocrine
|
|
Octreotide
|
Somatostatin analog
MECH: Inhibits growth hormone, glucagon, insulin, LH, 5HT, gastin VIP USE: acromegaly, carcinoid, gastrinoma, glucagonoma TOX: long QT |
endocrine
|
|
Desmopressin
|
ADH
USE: central diabetes insipidis |
endocrine
|
|
Oxytocin
|
USE: stimulate labor, uterine contractions
|
endocrine
|
|
Levothyroxine
|
MECH: thyroxine replacement
USE: hypothyroidism, myxedema TOX: tachycardia, heat intolerance, tremors |
endocrine
|
|
Triiodothyronine
|
MECH: thyroxine replacement
USE: hypothyroidism, myxedema TOX: tachycardia, heat intolerance, tremors |
endocrine
|
|
Glucocorticoids (hydrocortisone, prednisone, triamcinolone, dexamethasone, beclomethasone)
|
MECH:
Anti-inflammatory: inhibit phospholipase A2 →↓ production of leukotrienes and prostaglandins; inhibit release of histamine and 5HT Immunosuppression: inhibit production of IL-2 and T-lymphocytes USE: Addison's dz, inflammation, immune suppression, asthma/allergy TOX: Iatrogenic Cushing's |
endocrine, rheum
|
|
Ketoconazole
|
MECH: inhibits steroid synthesis
USE: Cushing dz TOX: liver dysfunction, gynecomastia |
endocrine
|
|
Democlocycline
|
MECH: impairs ADH (tetracycline)
USE: SIADH TOX: binds calcifying tissue |
|
|
Finasteride
|
MECH: 5 alpha-reductase inhibitor →↓conversion of T to DHT
USE: BPH; male-pattern baldness |
Male repro
|
|
Flutamide
|
MECH: nonsteroidal competitive inhibitor of androgens at T receptors
USE: prostate CA |
Male repro
|
|
Leuprolide
|
MECH: GnRH analog with agonist properties when used in a pulsatile fashion; antagonist when used continuously
USE: infertility, prostate cancer, uterine fibroids TOX: antiandrogen, N/V |
Reprp
|
|
Sildenafil, Vardenafil
|
MECH: inhibit cGMP phosphodiesterase →↑cGMP → smooth muscle relaxation in corpus cavernosum →↑blood flow → erection
USE: erectile dysfunction TOX: hypotension with nitrates, HA, flushing, dyspepsia, blue-green color conversion. |
Male repro
|
|
Clomiphene
|
MECH: partial agonist of estrogen receptors in pituitary gland → prevents normal feedback inhibition →↑release of LH and FSH → ovulation
USE: infertility TOX: hot flashes, ovarian enlargment, multiple simultaneous pregnancies, visual disturbances |
Female repro
|
|
Mifepristone (RU-486)
|
MECH: Competitive inhibitor of progestins at progesterone receptors
USE: postcoital abortifacient (prevents implantation) TOS: heavy bleeding, GI, abdominal pain |
|
|
Opiod analgesis (morphine, fentanyl, codeine, heroine, meperidine)
|
MECH: opioid receptor agonists modulate synaptic transmission
USE: pain, acute pulmonary edema TOX: addiction, respiratory depression, miosis (pinpoint pupils), additive CNS depression, constipation. Tox treated with naloxone/naltrexone |
|
|
Dextromethorphan
|
MECH: opioid receptor agonists modulate synaptic transmission
USE: cough suppression |
|
|
Methadone
|
MECH: opioid receptor agonists modulate synaptic transmission
USE: maintenance program for addicts TOX: addiction, respiratory depression, miosis (pinpoint pupils), additive CNS depression, constipation. Tox treated with naloxone/naltrexone |
|
|
Loperamide and diphenoxylate
|
MECH: opioid receptor agonists modulate synaptic transmission
USE: diarrhea |
|
|
Ibuprofen
|
NSAID
MECH: reversibly inhibits COX-1 and-2 →↓ prostaglandin synthesis USE: antipyretic, analgesic, anti-inflammatory TOX: renal damage, aplastic anemia, GI distress, ulcers |
Rheum
|
|
Naproxen
|
NSAID
MECH: reversibly inhibits COX-1 and-2 →↓ prostaglandin synthesis USE: antipyretic, analgesic, anti-inflammatory TOX: renal damage, aplastic anemia, GI distress, ulcers |
Rheum
|
|
Ketorolac
|
NSAID
MECH: reversibly inhibits COX-1 and-2 →↓ prostaglandin synthesis USE: antipyretic, analgesic, anti-inflammatory TOX: renal damage, aplastic anemia, GI distress, ulcers |
Rheum
|
|
Indomethacin
|
NSAID
MECH: reversibly inhibits COX-1 and-2 →↓ prostaglandin synthesis USE: close PDA TOX: renal damage, aplastic anemia, GI distress, ulcers |
Rheum
|
|
celecoxib, valdecoxib
|
COX-2 inhibitors
MECH: Reversibly inhibits COX-2, by sparing COX-1 it should allow maintenance of GI mucosa and not cause ulcers/bleeding USE: RA, osteoarthritis TOX: ↑risk of thrombosis |
Rheum
|
|
Acetaminophen
|
MECH: reversibly inhibits cyclooxygenase - mostly in CNS because inactivated peripherally
USE: antipyretic, analgesic TOX: OD → hepatic necrosis (metabolite depletes glutathione and forms toxic tissue adducts); Antidote = N-acetylcysteine → regenerates glutathione |
Rheum
|
|
Colchicine
|
MECH: depolymerizes microtubules impairing leukocyte chemotaxis and degranulation
USE: acute gout TOX: GI (given orally) |
Gout
|
|
Probenicid
|
MECH: inhibits reabsorption of uric acid; inhibits secretion of penicillin
USE: chronic gout |
Gout
|
|
Allopurinol
|
MECH: inhibits xanthine oxidase →↓conversion of xanthine to uric acid
USE: chronic gout; lymphoma/leukemia to prevent tumor lysis associated urate nephropathy |
Gout
|
|
Etanercept
|
MECH: recombinant TNF receptor that binds TNF-alpha
USE: RA, psoriasis, ankylosing spondylitis |
Rheum
|
|
Cyclosporine
|
MECH: binds cyclophilins → inhibits calcineurin → ↓IL-2 → ↓activation/differentiation of T cells
USE: suppress acute organ rejection after transplantation, autoimmune disorders TOX: ↑viral infection and lymphoma, nephrotox (preventable with mannitol diuresis) |
Rheum
|
|
Tacrolimus (FK506)
|
MECH: Binds FK-binding protein → ↓ IL-2 and other cytokines
USE: suppress acute organ rejection after transplantation TOX: significant - nephrotox, peripheral neuropathy, HTN, pleural effusion, hyperglycemia |
Rheum
|
|
Azathioprine
|
MECH: antimetabolite of 6-mercaptopurine that interferes with metabolism and synthesis of nucleic acids → toxic to proliferating lymphocytes
USE: kidney transplant, autoimmune disorders, glomerulonephritis, hemolytic anemia TOX: bone marrow suppression, metabolized by xanthine oxidase - tox ↑ by allopurinol (xanthine oxidase involved in metabolism) |
Rheum
|